“…It is necessary to point out that this is the first significant success in a 40-year effort to develop a procedure to be used in clinical practice, that modifies the negative effects of gamma radiation. The results of a study on hypoxyradiotherapy of pelvic tumors, including carcinoma of the cervix uteri, showed a dose modification factor (DMF) of 1.5 compared to conventional radiotherapy [24,25]. In a study on conventional externalbeam radiotherapy of cervical carcinoma, including the paraaortic lymphatic chain, a 60-Gy dose led to a considerable number of serious treatment complications and an increased mortality [31]; the same dose administered in acute hypoxia will cause no higher complication or mortality rate.…”
Section: Discussionmentioning
confidence: 99%
“…In a study on conventional externalbeam radiotherapy of cervical carcinoma, including the paraaortic lymphatic chain, a 60-Gy dose led to a considerable number of serious treatment complications and an increased mortality [31]; the same dose administered in acute hypoxia will cause no higher complication or mortality rate. Indeed, in comparison with the standard dose of 40 Gy applied under normal oxygenation conditions, administration of a 60-Gy dose in acute hypoxia paradoxically led to significantly less acute manifestations of postirradiation syndrome of the gastrointestinal tract (anorexia, nausea, and vomiting) and did not increase early or late complications of radiotherapy [25].…”
Section: Discussionmentioning
confidence: 99%
“…Theoretical assumptions of differential radioprotection by acute hypoxia to tumor and normal tissues have been verified experimentally [17,22,33,39] as well as clinically [1,23,24,[25][26][27][28]. Thus, induction of acute hypoxia has been introduced as a safe procedure allowing administration of radiation doses greater than the tolerance limits of normoxic tissues.…”
We believe it can be concluded that acute hypoxia has a radioprotective effect on normal tissues during accelerated hypoxyradiotherapy of colorectal carcinoma. Hypoxyradiotherapy permits safe administration of doses higher than those tolerated by normoxic, noncanceorus tissue, resulting in the amplification of the biological effect of radiation on tumor tissue and contributing to an improved outcome after combined radiosurgical treatment of colorectal carcinoma.
“…It is necessary to point out that this is the first significant success in a 40-year effort to develop a procedure to be used in clinical practice, that modifies the negative effects of gamma radiation. The results of a study on hypoxyradiotherapy of pelvic tumors, including carcinoma of the cervix uteri, showed a dose modification factor (DMF) of 1.5 compared to conventional radiotherapy [24,25]. In a study on conventional externalbeam radiotherapy of cervical carcinoma, including the paraaortic lymphatic chain, a 60-Gy dose led to a considerable number of serious treatment complications and an increased mortality [31]; the same dose administered in acute hypoxia will cause no higher complication or mortality rate.…”
Section: Discussionmentioning
confidence: 99%
“…In a study on conventional externalbeam radiotherapy of cervical carcinoma, including the paraaortic lymphatic chain, a 60-Gy dose led to a considerable number of serious treatment complications and an increased mortality [31]; the same dose administered in acute hypoxia will cause no higher complication or mortality rate. Indeed, in comparison with the standard dose of 40 Gy applied under normal oxygenation conditions, administration of a 60-Gy dose in acute hypoxia paradoxically led to significantly less acute manifestations of postirradiation syndrome of the gastrointestinal tract (anorexia, nausea, and vomiting) and did not increase early or late complications of radiotherapy [25].…”
Section: Discussionmentioning
confidence: 99%
“…Theoretical assumptions of differential radioprotection by acute hypoxia to tumor and normal tissues have been verified experimentally [17,22,33,39] as well as clinically [1,23,24,[25][26][27][28]. Thus, induction of acute hypoxia has been introduced as a safe procedure allowing administration of radiation doses greater than the tolerance limits of normoxic tissues.…”
We believe it can be concluded that acute hypoxia has a radioprotective effect on normal tissues during accelerated hypoxyradiotherapy of colorectal carcinoma. Hypoxyradiotherapy permits safe administration of doses higher than those tolerated by normoxic, noncanceorus tissue, resulting in the amplification of the biological effect of radiation on tumor tissue and contributing to an improved outcome after combined radiosurgical treatment of colorectal carcinoma.
“…The results of neutron brachytherapy treatment of cervical cancer and tumors of the oral cavity, using 252 Cf nuclide, show the potential to reach 80% local control of advanced tumors [4,5,9,11], as a consequence of breaking down the tumor resistance against conventional photon irradiation.…”
The technologic concept of the present automatic afterloading device for neutron brachytherapy represents a possible option from the range of conceivable design variants, which - while minimizing technologic and economic requirements - provides the operating personnel with optimum protection and work safety, thus extending the applicability of high LET radiation-based treatment methods in clinical practice.
“…Theoretical assumptions of differential radioprotection by acute hypoxia to tumor and normal tissues have been verified experimentally [21,29,45,52], as well as clinically [1,28,30,37,40,42,43].…”
The importance of the protective effects of hypoxyradiotherapy for dose escalation in external-beam irradiation of cervical carcinoma, including paraaortic lymph nodes, with regard to an improvement of the cure rates of metastases in paraaortic lymph nodes has been confirmed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.